Search results
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 11 hours agoBut virtually all of those cases were abroad: The drug never won approval as a sedative in the U.S....
FDA Approves Elanco’s New, First-in-Class Methane-Reducing Feed Ingredient
Dairy Herd· 6 days agoThe FDA has given its stamp of approval to Elanco's Bovaer®, a first-in-class methane-reducing feed ingredient.
Farming Today with KRVN: May 30, 2024
KHGI Nebraska TV· 6 days agoFDA approves methane-reducing feed ingredient for dairy cattle.HPAI strikes flock of 4.2 million chickens in Iowa.Loseke visits Japan and South Korea with USMEF
Exclusive: Former FDA official violated ethics rules by soliciting gifts from activists, watchdog...
BizPac Review· 14 hours agoProtect the Public’s Trust’s (PPT) complaint highlights emails showing that Kathy Crosby, who served in a high-level communications role at the FDA’s Center for Tobacco Products ...
Matthew Perry and the ketamine boom: Expensive, dangerous and very ‘en vogue’
Tampa Bay Times· 1 day agoWhen Los Angeles County medical examiners worked last year to determine how Matthew Perry died, they...
Gene therapy offers huge potential for combating disease, doctors say
United Press International via Yahoo News· 5 days agoResearchers are engineering ways to alter genes or swap flawed ones with healthy replacements,...
What’s keeping the U.S. from allowing better sunscreens?
Daily Montanan via Yahoo News· 4 days agoWhen dermatologist Adewole “Ade” Adamson sees people spritzing sunscreen as if it’s cologne at the...
Are ‘Ozempic Babies’ Real? Here’s What We Know About the Link Between Weight Loss Drugs and...
PureWow via AOL· 1 day ago“I got pregnant on a GLP-1” says TikTok user Deb Oliviara in a video from earlier this year. “Yes, I...
Health And Legal Ramifications Of Louisiana’s Restrictions On Abortion Pills
Forbes· 3 days agoLouisiana is criminalizing the abortion pills mifepristone and misoprostol, just two years after the...
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
Business Insider· 3 days agoThe anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a...